SYNTHECELL NAMES R&D VP ...Synthecell Corp. of Rockville, Md., said it has named Dr.Matthews O. Bradley as senior vice president for R&D at itsGenetic MediSyn subsidiary. Bradley, who comes from MerckSharp & Dohme Research Laboratories, will lead developmentof disease-specific applications of antisense and othergenetically based therapies. ... Isis Pharmaceuticals of San Diegonamed Executive Vice President Dr. Daniel Kisner to its board ofdirectors. Kisner, who joined Isis in February to lead productdevelopment, previously was division vice president ofpharmaceutical development at Abbott Laboratories.

(c) 1997 American Health Consultants. All rights reserved.